Strong AMR Opportunity Aequor’s portfolio includes 30 green, non-toxic antimicrobials pending EPA/FIFRA approval with potential to address antimicrobial resistance, presenting a compelling foothold for healthcare, hygiene, and industrial applications seeking safer disinfectants and coatings.

Green Biocides Demand With 25 EPA/TSCA-approved specialty chemicals ready for B2B licensing and consumer product ingredients to replace harmful biocides, there is a ready-made opportunity to partner with manufacturers seeking compliant, eco-friendly formulations for cleaners, coatings and water treatments.

Biofilm Expertise Founder is a recognized biofilm pioneer offering testing, training and consulting services to optimize product efficacy, enabling follow-on services for customers dealing with biofilm-related costs in healthcare, agro-industrial, and consumer segments.

Public Sector Access As a resident company at JLabs San Diego and a Woman Owned Small Business eligible for government contracts, Aequor can target federal and state procurement channels for antimicrobial, biofilm, and environmental health solutions.

Expansion Ready Pending FDA approvals for 30 drug candidates and NIH/DOD pre-clinical trial opportunities create a pathway for grant-backed collaborations and early-access studies, opening doors to biotech, pharma, and defense-related customers seeking novel therapeutics.